Parkinson’s disease Prevalence Study

Posted on by Phil Franchina

New Parkinson’s disease prevalence study Trying to estimate the number of people living with Parkinson’s disease (PD) in North...see more America is extremely important but notoriously difficult. It is critical to know the prevalence of PD because it informs lawmakers who make decisions concerning allocation of research funds about the true impact of the disease, and […]

Read More

Deep Brain Stimulation May Slow Tremor Progression

Posted on by Phil Franchina

Deep brain stimulation may slow the progression of tremor if performed in early Parkinson’s disease. APDA funding is helping...see more further the efforts to find out more. New results, published in the June 29, 2018, online issue of Neurology suggest that deep brain stimulation (DBS) may slow the progression of tremor if performed early on in […]

Read More

Ask the Doctor

Posted on by Phil Franchina

Dr. Terry Ellis, Assistant Professor at Boston University College of Health & Rehabilitation Sciences, Director of...see more the Center for Neurorehabilitation, Advisor for the APDA Massachusetts Chapter. Q. What is the best kind of exercise for Parkinson’s? A. There are several types of exercise that are important for people with Parkinson’s disease. Aerobic […]

Read More

New Information & Referral Centers Support PD Communities Nationwide

Posted on by Phil Franchina

New Information & Referral Centers Support PD Communities Nationwide APDA is thrilled to announce the opening of three new...see more Information & Referral (I&R) Centers across the country! In San Francisco, CA; Vernon, CT, and Chicago, IL, we are expanding the reach of our vital services to people with Parkinson’s disease (PD) and their care partners. […]

Read More

APDA SCIENTIFIC ADVISORY BOARD EVALUATES EXCITING RESEARCH IDEAS FOR 2018-2019 RESEARCH FUNDING

Posted on by Phil Franchina

Established and Up-and-Coming Researchers Vie for More Than $1,700,000 in Funding NEW YORK, NY, May 24, 2018 – The...see more American Parkinson Disease Association’s (APDA) Scientific Advisory Board recently met to review 70 grant submissions all vying for funding to be awarded in the field of Parkinson’s research. In addition, the Scientific Advisory Board (SAB) reviewed […]

Read More

APDA Updates Regarding PD Psychosis Treatment

Posted on by Phil Franchina

On April 9, 2018, CNN published an article on the drug, Nuplazid, the only FDA-approved medication for the treatment...see more of Parkinson’s disease psychosis. The American Parkinson Disease Association (APDA) recommends that patients discuss with their neurologists any concerns about the drug that the article may have raised. The FDA continues to monitor safety of this […]

Read More

AMERICAN PARKINSON DISEASE ASSOCIATION ANNOUNCES REBECCA GILBERT, MD, PhD JOINS STAFF

Posted on by Phil Franchina

AMERICAN PARKINSON DISEASE ASSOCIATION ANNOUNCES REBECCA GILBERT, MD, PhD, JOINS STAFF AS VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER Role designed...see more to shape research strategy to help those impacted by Parkinson’s disease live life to the fullest NEW YORK, NY – April 9, 2018 – The American Parkinson Disease Association (APDA) proudly welcomes Rebecca Gilbert, MD, PhD, in […]

Read More